Shares of Polydex Pharmaceuticals Ltd. (OTCMKTS:POLXF – Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $1.99 and traded as low as $1.9860. Polydex Pharmaceuticals shares last traded at $1.9860, with a volume of 2,000 shares.
Polydex Pharmaceuticals Stock Up 0.3%
The company’s fifty day simple moving average is $1.99 and its 200 day simple moving average is $1.99.
Polydex Pharmaceuticals Company Profile
Polydex Pharmaceuticals Ltd. is a development stage company, which engages in manufacturing of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry, and the development, manufacturing, and marketing of biotechnology-based products for the human pharmaceutical market. The firm focuses on Dextran and derivative products, including Iron Dextran and Dextran Sulphate and other specialty chemicals. The company was founded by Thomas C. Usher on June 14, 1979 and is headquartered in Toronto, Canada.
Featured Stories
- Five stocks we like better than Polydex Pharmaceuticals
- ALERT: Drop these 5 stocks before January 2026!
- Buy This Stock Now
- Trump & Musk’s Secret Bet on Silver — Exposed
- Silicon Valley insiders hint at 12-month AI warning
- Your Bank Account Is No Longer Safe
Receive News & Ratings for Polydex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polydex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
